These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 28551810)

  • 1. Mitochondria-Targeted Antioxidants for the Treatment of Cardiovascular Disorders.
    Kim HK; Han J
    Adv Exp Med Biol; 2017; 982():621-646. PubMed ID: 28551810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting mitochondria for cardiac protection.
    Hernández-Reséndiz S; Buelna-Chontal M; Correa F; Zazueta C
    Curr Drug Targets; 2013 May; 14(5):586-600. PubMed ID: 23458575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Molecular Mechanism of Aluminum Phosphide poisoning in Cardiovascular Disease: Pathophysiology and Diagnostic Approach.
    Hosseini SF; Forouzesh M; Maleknia M; Valiyari S; Maniati M; Samimi A
    Cardiovasc Toxicol; 2020 Oct; 20(5):454-461. PubMed ID: 32712815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial reactive oxygen species at the heart of the matter: new therapeutic approaches for cardiovascular diseases.
    Kornfeld OS; Hwang S; Disatnik MH; Chen CH; Qvit N; Mochly-Rosen D
    Circ Res; 2015 May; 116(11):1783-99. PubMed ID: 25999419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Role of Mitochondria in Arrhythmogenesis.
    Gambardella J; Sorriento D; Ciccarelli M; Del Giudice C; Fiordelisi A; Napolitano L; Trimarco B; Iaccarino G; Santulli G
    Adv Exp Med Biol; 2017; 982():191-202. PubMed ID: 28551788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfur Dioxide Contributes to the Cardiac and Mitochondrial Dysfunction in Rats.
    Qin G; Wu M; Wang J; Xu Z; Xia J; Sang N
    Toxicol Sci; 2016 Jun; 151(2):334-46. PubMed ID: 26980303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial Dysfunction in Cardiovascular Aging.
    Hoppel CL; Lesnefsky EJ; Chen Q; Tandler B
    Adv Exp Med Biol; 2017; 982():451-464. PubMed ID: 28551802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial Mechanosensor Microdomains in Cardiovascular Disorders.
    Miragoli M; Cabassi A
    Adv Exp Med Biol; 2017; 982():247-264. PubMed ID: 28551791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria in Structural and Functional Cardiac Remodeling.
    Torrealba N; Aranguiz P; Alonso C; Rothermel BA; Lavandero S
    Adv Exp Med Biol; 2017; 982():277-306. PubMed ID: 28551793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondria and arrhythmias.
    Yang KC; Bonini MG; Dudley SC
    Free Radic Biol Med; 2014 Jun; 71():351-361. PubMed ID: 24713422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological approaches to the treatment of oxidative stress-induced cardiovascular dysfunctions.
    Zamora PL; Villamena FA
    Future Med Chem; 2013 Mar; 5(4):465-78. PubMed ID: 23495692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial Proton Leak Plays a Critical Role in Pathogenesis of Cardiovascular Diseases.
    Cheng J; Nanayakkara G; Shao Y; Cueto R; Wang L; Yang WY; Tian Y; Wang H; Yang X
    Adv Exp Med Biol; 2017; 982():359-370. PubMed ID: 28551798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolution of mitochondrial oxidant stress improves aged-cardiovascular performance.
    Owada T; Yamauchi H; Saitoh SI; Miura S; Machii H; Takeishi Y
    Coron Artery Dis; 2017 Jan; 28(1):33-43. PubMed ID: 27740971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin E confers cytoprotective effects on cardiomyocytes under conditions of heat stress by increasing the expression of metallothionein.
    Wang X; Dong W; Yuan B; Yang Y; Yang D; Lin X; Chen C; Zhang W
    Int J Mol Med; 2016 May; 37(5):1429-36. PubMed ID: 27035111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Overview on Arsenic Trioxide-Induced Cardiotoxicity.
    Vineetha VP; Raghu KG
    Cardiovasc Toxicol; 2019 Apr; 19(2):105-119. PubMed ID: 30617460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrially targeted antioxidants for the treatment of cardiovascular diseases.
    Subramanian S; Kalyanaraman B; Migrino RQ
    Recent Pat Cardiovasc Drug Discov; 2010 Jan; 5(1):54-65. PubMed ID: 19807685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting mitochondrial dysfunction and oxidative stress in heart failure: Challenges and opportunities.
    Kiyuna LA; Albuquerque RPE; Chen CH; Mochly-Rosen D; Ferreira JCB
    Free Radic Biol Med; 2018 Dec; 129():155-168. PubMed ID: 30227272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial redox status as a target for cardiovascular disease.
    Walters JW; Amos D; Ray K; Santanam N
    Curr Opin Pharmacol; 2016 Apr; 27():50-5. PubMed ID: 26894468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting antioxidants to mitochondria: a potential new therapeutic strategy for cardiovascular diseases.
    Victor VM; Rocha M
    Curr Pharm Des; 2007; 13(8):845-63. PubMed ID: 17430185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of mitochondrion-toxic agents on the cardiovascular system.
    Finsterer J; Ohnsorge P
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):434-45. PubMed ID: 24036395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.